As psychedelic research has grown, limitations of the research have been identified by researchers both within and outside the psychedelic field As of July 1, authorised psychiatrists have been allowed to prescribe MDMA (the chemical found in "ecstasy") to treat post-traumatic stress disorder (PTSD), and psilocybin (found in "magic mushrooms") to treat depression that hasn't responded to other treatment. Psychedelic therapies have researchers excited because evidence suggests they might have lasting beneficial effects on factors that cause psychological distress beyond the treatment period.

https://www.miragenews.com/evidence-reveals-efficacy-of-psychedelics-in-1041477/

#miragenews